Metraipolis › archive › dc_12969f74ee97

Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types — Europe PMC PMID:41519763

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41519763
DOI: 10.1186/s12885-[numero omesso]-5
License (as archived): solo-consultazione
Archived: 2026-11-06T22:27:06.371Z
SHA-256 of the archived text: d2ce0383db2bcd2ba687e0be302fb7e9051252a42b062705255972d2e1dbd3f1
Stable URL of this page: https://metraipolis.com/documento/dc_12969f74ee97

How to cite

Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types — Europe PMC PMID:41519763 — Europe PMC (en), https://europepmc.org/article/MED/41519763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12969f74ee97 (Metraipolis archive dc_12969f74ee97, sha256 d2ce0383db2bcd2ba687e0be302fb7e9051252a42b062705255972d2e1dbd3f1)

BibTeX

@misc{dc12969f74ee97,
  title = {Glucose-transporter 1 (GLUT1) as a prognostic biomarker: evidence from 14,966 human tumors across 134 cancer types — Europe PMC PMID:41519763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41519763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12969f74ee97; sha256 d2ce0383db2bcd2ba687e0be302fb7e9051252a42b062705255972d2e1dbd3f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41519763. Agents can read the archived copy with the MCP tool read_document.